English

Interim report 1 January – 31 March 2011

Report this content

Three months ended 31 March 2011

  • Local currency sales increased by 7% and Euro sales increased by 10% to €396.8m (€361.9m). Excluding Oriflame's discontinued business in Iran, sales growth was 10% in local currency.
  • Average size of the sales force increased by 9% to 3.8m consultants and closing sales force was up by 8%.
  • EBITDA amounted to €53.3m (€49.3m).
  • Adjusted operating margin was 11.8% (11.7%) resulting in an adjusted operating profit of €46.7m (€42.2m).
  • Adjusted net profit amounted to €31.5m (€37.2m).
  • Adjusted EPS after dilution amounted to €0.55 (€0.65).
  • Cash flow from operating activities amounted to €16.5m (€20.7m).

 
“I am pleased to see a strong growth in Asia and a turnaround in the EMEA region with several of our large markets growing with increased profitability. This is driving overall profitability for the company and I feel confident that we will be able to deliver on our outlook for the full year despite the unpredictable market conditions in our core markets in Eastern Europe and CIS,” CEO Magnus Brännström comments. 

 

For further information, please contact:

Magnus Brännström, Chief Executive Officer       Telephone: +35 269 115 1930
Gabriel Bennet, Chief Financial Officer                Telephone: +41 798 263 713
Patrik Linzenbold, Sr. Director Investor Relations until 1 June    Telephone: +46 765 422 709
Joakim Banestig, Sr. Director Investor Relations after 1 June      Telephone: +41 79 103 35 21

Oriflame Cosmetics S.A.
24 Avenue Emile Reuter, L-2420, Luxembourg
www.oriflame.com
Company registration no B.8835

Documents & Links